A multicenter non-randomized confirmatory trial of stereotactic body radiation therapy for solitary lung tumor after complete resection of non-small cell lung cancer (JROSG17-4)
Not Applicable
Recruiting
- Conditions
- Solitary lung tumor within 3 years after complete resection of non-small cell lung cancer: patients with medically inoperable or refusing surgery: small lung lesion with the diameter of 3 cm or less
- Registration Number
- JPRN-UMIN000038935
- Lead Sponsor
- Japanese Radiation Oncology Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1.Lung lesion diagnosed as small cell lung cancer or large cell neuroendocrine cancer 2.Synchronous or metachronous malignancy within 3 years 3.Active infection requiring systemic therapy 4.Body temperature of 38 or more degrees Celsius 5.Woman during pregnancy or possible pregnancy, within 28 days after delivery, or during breast-feeding 6.Severe mental disease 7.Receiving continuous systemic steroid (more than 10mg/day of prednisolone) or immune-suppressive medication 8.Idiopathic pulmonary fibrosis on CT 9.Severe cough requiring narcortic drugs 10.Inappropriate patients for this study judged by physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method Progression-free survival, local progression-free survival, patterns of failure, local control period, early and late adverse events, severe adverse events